Stuart C. Wilson

Targeting the α-folate receptor with cyclopenta[g]quinazoline-based inhibitors of thymidylate synthase

Elisa Henderson, Vassilios Bavetsias, Davinder S. Theti et al. · Bioorganic & Medicinal Chemistry · 2006 · 135 citations

Molecular Pharmacology, Drug Target, Drug Targeting +8

Mechanism-Based Screen for G1/S Checkpoint Activators Identifies a Selective Activator of EIF2AK3/PERK Signalling

Simon R. Stockwell, Georgina Platt, S. Elaine Barrie et al. · PLoS ONE · 2012 · 112 citations · Full text

Reverse Genetics, Molecular Regulation, Molecular Biology +22

Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouse.

Bernard Nutley, Florence I. Raynaud, Stuart C. Wilson et al. · PubMed · 2005 · 71 citations

Design, Synthesis, and Evaluation of a Novel Sequence-Selective Epoxide-Containing DNA Cross-Linking Agent Based on the Pyrrolo[2,1-<i>c</i>][1,4]benzodiazepine System

Stuart C. Wilson, Philip W. Howard, Stephen Forrow et al. · Journal of Medicinal Chemistry · 1999 · 64 citations

An evaluation of the ability of pifithrin-α and -β to inhibit p53 function in two wild-type p53 human tumor cell lines

Mike I. Walton, Stuart C. Wilson, Ian R. Hardcastle et al. · Molecular Cancer Therapeutics · 2005 · 64 citations · Full text